Showing posts with label AfricanAmericans. Show all posts
Showing posts with label AfricanAmericans. Show all posts
Monday, July 4, 2011

Storytelling may help control blood pressure in African-Americans

ScienceDaily (Jan. 18, 2011) — Controlling blood pressure is not only a medical challenge, but a social one as well. Because patients are required to strictly adhere to a treatment plan that may include medication, dietary restrictions and regular doctor visits, the ideas of wellness and health are also powerful parts of the social reinforcement needed for behavioral change.

This is especially true in the African American population, which is particularly susceptible to hypertension. Social and cultural barriers have been found to contribute to African American patients being far more likely than white patients to suffer from uncontrolled high blood pressure and resulting complications.

A new study suggests that a storytelling approach -- in which recognizable members of a community provide positive messages aimed at controlling hypertension through diet and medication adherence -- may offer a unique opportunity to communicate positive disease management choices in a culturally appropriate context.

Researchers at UMass Medical School, working with colleagues at Cooper Green Mercy Hospital and the University of Alabama at Birmingham have identified one promising approach. They identified "exceptionally eloquent and persuasive" patients with hypertension from focus groups where blood pressure control and the benefits of intervention were discussed; these volunteers were then videotaped, and edited DVDs, distilled from 80 hours of taping, were created.

The study appears in the Jan. 18 issue of the Annals of Internal Medicine. Researchers randomly assigned 299 African American patients with hypertension to receive either usual care or to view three videos that presented stories of real patients with hypertension. Among patients who had uncontrolled hypertension, those assigned to view the stories had better blood pressure control than those assigned to usual care -- the first such study that based a health intervention for hypertensive African Americans on positive, culturally sensitive storytelling.

"Overall," the authors wrote, "Among the 300 patients randomized, we found a difference in blood pressure favoring the intervention group, and the significance of this difference was driven by the positive effect among those with uncontrolled blood pressure. Patients with uncontrolled hypertension who were randomized to the intervention group experienced a 10 mmHg advantage in systolic blood pressure reduction relative to control Meaningful advantages were also found for diastolic pressure among the uncontrolled substrata. Blood pressures for both groups subsequently increased over time, but the relative advantage for the intervention group was maintained until the end of follow up."

What accounts for the result? Although there is no direct evidence about the mechanism by which the intervention worked, the researchers believe that the DVDs provided a "parasocial" interaction, one that rendered the viewer of the messages more susceptible to behavior change. "In prior hypertension work, we…translated patient stories into re-enactments using trained actors using high production quality in studio. To maximize [the] para-social interaction [in this study], we enhanced the realism of the current intervention by purposefully avoiding the studio, taping patients in the actual hypertension clinic."

Authors included Thomas K. Houston, MD, MPH, professor of quantitative health sciences and division chief, health informatics and implementation science; Jeroan J. Allison, MD, MSc, vice chair and professor of quantitative health sciences; John Trobaugh, MFA; Yendelela L. Cuffee, MPH; Bruce Barton PhD, research professor of quantitative health sciences; and Catarina I. Kiefe, PhD, MD, professor and chair of quantitative health sciences.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by University of Massachusetts Medical School, via EurekAlert!, a service of AAAS.

Journal Reference:

Houston et al. Culturally Appropriate Storytelling to Improve Blood Pressure: A Randomized Trial. Annals of Internal Medicine, 2011;

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.


View the original article here

Tuesday, April 19, 2011

African-Americans with high blood pressure need treatment sooner, more aggressively, experts urge

ScienceDaily (Oct. 4, 2010) — According to a consensus statement by the International Society on Hypertension in Blacks (ISHIB), high blood pressure in African-Americans is such a serious health problem that treatment should start sooner and be more aggressive. The ISHIB statement is published in Hypertension: Journal of the American Heart Association.

Complications related to high blood pressure such as stroke, heart failure and kidney damage occur much more frequently in African-Americans compared with whites.

"Evidence from several recently completed studies converged to convince our committee that we were waiting a little bit too long to start treating hypertension in African-Americans," said John M. Flack, M.D., M.P.H., lead author and chairman of the Department of Internal Medicine at Wayne State University in Detroit.

The update to the ISHIB's 2003 consensus statement makes two major recommendations: First, the thresholds at which African-American patients begin treatment should be lowered. Second, doctors should move quickly from single-drug therapy to multi-drug therapy to keep a patient's blood pressure comfortably below the thresholds.

"We believe that these recommendations will lead to better blood pressure control, and a better outlook for African-Americans with high blood pressure," Flack said.

Blood pressure is reported as two numbers, measured in millimeters of mercury (mm Hg). The top number represents the pressure in the arteries when the heart beats and the lower number reflects the pressure when the heart relaxes between beats.

Blood pressure below 120/80 is considered normal for healthy U.S. adults. However, the ISHIB proposes that doctors recommend lifestyle changes to lower blood pressure in otherwise healthy African-Americans with blood pressure at or above 115/75. Those changes include reduced dietary sodium (salt) and increased potassium from eating more fruits and vegetables, as well as losing weight if necessary, getting regular aerobic exercise and drinking in moderation, Flack said.

"Epidemiological data shows that 115/75 is the critical blood pressure number for adults, and every time that figure goes up by 20/10 the risk of cardiovascular disease essentially doubles. We think it makes perfect sense to start lifestyle changes at that lower threshold," he said. "The natural history of blood pressure is that it continues to go up as a person ages. In fact, from the age of 50 and onward, Americans have a 90 percent chance of developing hypertension."

Doctors currently begin drug therapy to reduce blood pressure in patients without a history of cardiovascular disease, diabetes or high blood pressure-related organ-damage when blood pressure is at or above 140/90. This is referred to as primary prevention. The ISHIB recommends tightening the primary prevention threshold to 135/85 for African-Americans.

In addition, the ISHIB recommends starting treatment earlier for African-Americans who have cardiovascular disease, diabetes, kidney disease or damage to target organs (the heart, brain, kidneys). This treatment, known as secondary prevention, should start when blood pressure is at or above 130/80, according to the ISHIB statement.

The ISHIB also recommends that doctors move swiftly from single-drug therapy to multi-drug therapy if one agent doesn't lower the pressure.

"The majority of patients of any race, and certainly African-Americans, are going to need more than one drug to be consistently controlled below their goal," Flack said. "The debate in the medical community over which single drug is best overwhelms the most pressing question: Which drugs work best together?"

Based on a review of recently completed studies, the ISHIB document provides doctors with step-by-step guidance on the best second, third and fourth drugs to add based on individual patient characteristics. The ISHIB statement provides charts with alternate multi-drug combinations so physicians have several options for keeping patients' blood pressure under targets, Flack said.

Flack stressed that the ISHIB tried whenever possible to suggest cheaper generic drugs to keep cost from becoming a treatment barrier.

"These guidelines raise the question for addressing issues surrounding treatment strategies and goals for African-Americans with hypertension," said Sidney C. Smith Jr., M.D., an American Heart Association spokesman and professor of medicine at the University of North Carolina School of Medicine in Chapel Hill, N.C. "Studies continue to accumulate that address ethnic, age and gender differences, as well as optimal therapies."

A major comprehensive statement regarding hypertension is expected to be published by the National Institutes of Health (NIH) by late 2011, Smith said.

The American Heart Association participates as a member organization in the NIH Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC) guidelines.

Co-authors of the ISHIB statement are: Domenic A. Sica, M.D.; George Bakris, M.D.; Angela L. Brown, M.D.; Keith C. Ferdinand, M.D.; Richard H. Grimm, Jr., M.D., Ph.D.; W. Dallas Hall, M.D.; Wendell E. Jones, M.D.; David S. Kountz, M.D.; Janice P. Lea, M.D.; Samar Nasser, P.A.-C., M.P.H.; Shawna D. Nesbitt, M.D.; Elijah Saunders, M.D.; Margaret Scisney-Matlock, R.N., Ph.D. and Kenneth A. Jamerson, M.D. Individual author disclosures are on the manuscript.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by American Heart Association, via EurekAlert!, a service of AAAS.

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.


View the original article here